Valuation: ResMed, Inc.

Market Cap 2.82TCr 2.47TCr 2.3TCr 2.11TCr 3.97TCr 2,71200Cr 4.03TCr 27TCr 11TCr 1,33400Cr 11TCr 10TCr 4,61100Cr P/E 2026 *
18.4x
P/E 2027 * 17.2x
Enterprise Value 2.73TCr 2.4TCr 2.23TCr 2.05TCr 3.85TCr 2,63300Cr 3.91TCr 27TCr 10TCr 1,29400Cr 10TCr 10TCr 4,47500Cr EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.44x
Free-Float
75.61%
Yield 2026 *
1.25%
Yield 2027 * 1.34%
1 day+1.76%
1 week-1.87%
Current month+0.20%
1 month-1.68%
3 months-11.18%
6 months-22.63%
Current year-18.93%
1 week 190.21
Extreme 190.21
198.73
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%-1.87%-29.03%-11.24% 2.82TCr
-0.71%+6.72%+18.80%-0.46% 21TCr
-0.52%-6.05%-6.80%-25.11% 13TCr
+1.65%-2.29%-31.94%+1.99% 12TCr
+1.54%+0.50%-58.31%-15.57% 6.58TCr
-1.42%-3.62%+3.29%-9.87% 4.76TCr
+3.03%-0.17%-26.91%-33.60% 4.44TCr
-0.84%+5.41%+15.30%+8.84% 3.91TCr
-2.02%+1.54%+23.68%+30.76% 3.68TCr
-1.41%+3.99%+77.58%+2.50% 2.94TCr
Average +0.11%-0.11%-1.44%-5.17% 7.56TCr
Weighted average by Cap. +0.06%+0.15%-3.57%-6.60%

Financials

2026 *2027 *
Net sales 565.06Cr 496.29Cr 461.54Cr 423.52Cr 795.76Cr 54TCr 808.03Cr 5.48TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 596.78Cr 524.15Cr 487.45Cr 447.3Cr 840.44Cr 57TCr 853.39Cr 5.79TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 98TCr
Net income 154.63Cr 135.81Cr 126.3Cr 115.9Cr 217.77Cr 15TCr 221.12Cr 1.5TCr 585.96Cr 7.32TCr 580.49Cr 567.98Cr 25TCr 161.15Cr 141.54Cr 131.63Cr 120.79Cr 226.95Cr 16TCr 230.45Cr 1.56TCr 610.67Cr 7.63TCr 604.96Cr 591.93Cr 26TCr
Net Debt -83Cr -73Cr -68Cr -62Cr -116.42Cr -7.96TCr -118.21Cr -801.79Cr -313.25Cr -3.91TCr -310.32Cr -303.64Cr -14TCr -164.65Cr -144.62Cr -134.49Cr -123.41Cr -231.88Cr -16TCr -235.46Cr -1.6TCr -623.94Cr -7.8TCr -618.11Cr -604.79Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
24/26/24 $195.27 +1.76% 10,05,232
23/26/23 $191.89 -0.53% 10,12,467
22/26/22 $192.91 -1.48% 9,71,174
21/26/21 $195.80 -1.41% 11,12,740
20/26/20 $198.61 -0.19% 10,37,424
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
195.27USD
Average target price
248.60USD
Spread / Average Target
+27.31%

Quarterly revenue - Rate of surprise